Background: Brain tissue oxygenation (PbtO 2 )-guided management facilitates treatment of reduced PbtO 2 episodes potentially conferring survival and outcome advantages in severe traumatic brain injury (TBI). To date, the nature and effectiveness of commonly used interventions in correcting compromised PbtO 2 in TBI remains unclear. We sought to identify the most common interventions used in episodes of compromised PbtO 2 and to analyze which were effective. Methods: A retrospective 7-year review of consecutive severe TBI patients with a PbtO 2 monitor was conducted in a Level I trauma center's intensive care unit or neurosurgical registry. Episodes of compromised PbtO 2 (defined as Ͻ20 mm Hg for 0.25-4 hours) were identified, and clinical interventions conducted during these episodes were analyzed. Response to treatment was gauged on how rapidly (⌬T) PbtO 2 normalized (Ͼ20 mm Hg) and how great the PbtO 2 increase was (⌬PbtO 2 ). Intracranial pressure (⌬ICP) and cerebral perfusion pressure (⌬CPP) also were examined for these episodes. Results: Six hundred twenty-five episodes of reduced PbtO 2 were identified in 92 patients. Patient characteristics were: age 41.2 years, 77.2% men, and Injury Severity Score and head or neck Abbreviated Injury Scale score of 34.0 Ϯ 9.2 and 4.9 Ϯ 0.4, respectively. Five interventions: narcotics or sedation, pressors, repositioning, FIO 2 /PEEP increases, and combined sedation or narcotics ϩ pressors were the most commonly used strategies. Increasing the number of interventions resulted in worsening the time to PbtO 2 correction. Triple combinations resulted in the lowest ⌬ICP and dual combinations in the highest ⌬CPP (p Ͻ 0.05). Conclusion: Clinicians use a limited number of interventions when correcting compromised PbtO 2 . Using strategies employing many interventions administered closely together may be less effective in correcting PbO 2 , ICP, and CPP deficits. Some PbtO 2 deficits may be self-limited.
T raumatic brain injury (TBI) remains a major cause of mortality and morbidity in young people worldwide and has a significant long-term socioeconomic impact. In particular, severe TBI (Glasgow Comas Scale [GCS] Յ8) is associated with 30% mortality and significant disability among survivors. 1 To date, there is no effective drug treatment for TBI. Instead, management is centered on identifying and managing the secondary brain injury that evolves in the hours and days after TBI. Secondary injury is known to occur with cerebral underperfusion but also may occur with dysfunctional cerebral metabolism, tissue hypoxia, and inflammation and contributes to further tissue destruction. [2] [3] [4] Although there is no Level I evidence to suggest that management of intracranial pressure (ICP) is associated with better outcome, the use of an ICP monitor is endorsed by major medical societies (The Brain Trauma Foundation [BTF] , The European Brain Injury Consortium, The American Association of Neurologic Surgeons, and The Congress of Neurologic Surgeons Joint Section on Neurotrauma and Critical Care). 5, 6 Several lines of evidence suggest that reduced brain oxygen is not a benign event and that compromised brain oxygen (Ͻ20 mm Hg) or brain hypoxia (variably defined as Ͻ15 or 10 mm Hg) is associated with increased mortality and unfavorable outcome. [7] [8] [9] [10] Consistent with this, nonrandomized clinical studies indicate that therapy based on both an ICP and brain oxygenation (PbtO 2 ) monitor is associated with better outcome than management with only an ICP monitor. [11] [12] [13] [14] [15] [16] There are, however, several unanswered questions about PbtO 2 -based care including what are available treatments to improve brain oxygenation, how effective are they, and how do they affect traditional management parameters such as ICP and cerebral perfusion pressure (CPP)? This retrospective study was conducted to (1) identify the most common interventions administered by neurosurgeons and intensivists during short (Ͻ4 hours) episodes of low PbtO 2 and (2) whether these interventions (alone or in combination) resulted in significant benefits in rapidly correcting PbtO 2 deficits and improving ICP and CPP.
METHODS

Patient Population
All blunt TBI patients admitted to the intensive care unit (ICU) of an academic Level I trauma center who had a parenchymal intracranial monitor able to measure partial brain tissue oxygen tension (PbtO 2 ) between October 2001 and September 2008 were considered for study. Patients were retrospectively identified from a prospective observational database, the Brain Oxygen Monitoring Outcomes (BOMO) registry, which has Institutional Review Board approval. Patients with gunshot wounds or other penetrating cranial injuries, ongoing blood loss, or whose postresuscitation systolic blood pressure was Ͻ90 mm Hg and arterial oxygen saturation (SaO 2 ) Ͻ93% were excluded from analysis. Patients in whom pupils were bilaterally fixed and dilated or were brain dead or imminently dead on admission also were excluded.
Brain Intraparenchymal Monitors
ICP, brain temperature, and brain tissue oxygen (PbtO 2 ) were continuously monitored using a commercially available intracranial device (LICOX; Integra LifeSciences, Plainsboro, NJ). All three intracranial monitors were inserted at the bedside through the same burr-hole into the frontal lobe and secured with a triple-lumen bolt. The PbtO 2 monitor was placed into white matter that appeared normal on the admission head CT and on the side of maximal pathology. Brain tissue oxygenation data were acquired after a stabilization period of 2 hours after probe insertion. Probe function and location were confirmed by an appropriate increase in PbtO 2 after an hyperoxic FIO 2 challenge (FIO 2 ϭ 100%) 17 and a head CT scan to verify correct placement of the various monitors, e.g., not in a contusion or infarct. CPP was calculated from measured parameters (CPP ϭ mean arterial pressure [MAP] Ϫ ICP). All intracranial monitors were removed when ICP was normal for 24 hours without specific treatment other than sedation for ventilation, when the patient was able to follow commands or when the patient was brain dead.
Physiologic Monitors
Heart rate, arterial line blood pressures, and arterial oxygen saturations (SaO 2 ) were monitored continuously (Component Monitoring System M1046-9090C: Hewlett Packard, Andover, MA). The MAP was derived from arterial lines with transducers leveled at the phlebostatic axis. Central venous pressures and pulmonary artery pressures were followed in patients with intravascular depletion or cardiopulmonary compromise. Ͼ93%, (3) sedation using propofol during the first 24 hours followed by sedation and analgesia using lorazepam, morphine, or fentanyl, (4) bedrest with head elevation of Ն30 degrees, (5) normothermia ϳ35°C to 37°C, (6) euvolemia using a baseline crystalloid infusion (0.9% normal saline, 20 mEq/L KCl; 80 -100 mL/h), (7) anticonvulsant prophylaxis with phenytoin for 1 week or longer if seizures occurred, and (8) packed red blood cell transfusion if their Hgb was Ͻ7.
General Clinical Management of TBI
Management of Intracranial Hypertension
If ICP remained persistently elevated (Ͼ20 mm Hg Ͼ10 min) despite baseline initial measures, osmotherapy was administered using repeated boluses of mannitol (1 gm/kg, 25% solution) provided that serum osmolar gap Ͻ20. Second tier therapies for refractory intracranial hypertension (Ͼ20 mm Hg Ͼ15 minutes in a 1-hour period despite therapy) included optimized hyperventilation (PaCO 2 30 -35 mm Hg), decompressive craniectomy, or pharmacological coma (with propofol or pentobarbital). Induced hypothermia and hypertonic saline for ICP control were used to manage ICP in the patients included during the last 2.5 years of this study.
Evaluation of Brain Oxygen Treatment
During the study period patients received "cause" directed therapy at the intensivist's discretion to maintain PbtO 2 Ն20 mm Hg according to our local protocol (Fig. 1) . The BOMO registry records and codes every event noted by a bedside nurse in the chart and also records hemodynamics, cerebral parameters, and other nursing entries every 10 minutes to 20 minutes. There was Ͼ8000 hours of PbtO 2 monitoring in eligible patients available for review. Episodes where PbtO 2 was Ͻ20 mm Hg for Ͼ15 minutes but Ͻ4 hours were abstracted. There have been several important described thresholds for PbtO 2 that identify when cell death or ischemia may be evident and at what level to treat. We chose a PbtO 2 threshold of 20 mm Hg because this corresponds to the minimal necessary oxygen tension for mitochondria, where the majority of cellular oxygen metabolism occurs to maintain aerobic metabolism. 18 In addition, it is the threshold being used in a current NIH-funded trial to prospectively examine PbtO 2 in TBI. We chose a 15-minute minimum time window to eliminate incidental, self-limited episodes of compromised PbtO 2 and to allow time for a 2-minute oxygen challenge as required by protocol to test monitor function. Thus, this brief FIO 2 challenge was not considered therapeutic and so was excluded from analysis. We chose a 4-hour maximum to avoid inclusion of patients who no longer were receiving active treatment for PbtO 2 deficits by bedside clinicians. Also this was done to avoid the inclusion of episodes where clinicians were aggressively using all possible interventions in the setting of a resistant compromised PbtO 2 .
We consulted seasoned intensivists, neurologists, trauma surgeons, and neurosurgeons who cared for brain injured patients to achieve a consensus of what therapies were considered useful to correct PbtO 2 deficits. Eleven interventions were selected by the panel and thereafter identified from the coded treatments in the BOMO registry. They are presented in Table 1 .
During each episode of PbtO 2 compromise, various registry parameters were recorded before the decrease and on correction of the PbtO 2 deficit (Ͼ20 mm Hg 
Outcome Assessment
Discharge disposition was recorded for all patients. In patients who survived past discharge, a functional outpatient evaluation interview 3-to 6-month postdischarge was obtained using the Glasgow Outcome Score-extended (GOS-e) 19 and modified Rankin Scale (mRS) 20 scores. These data are acquired routinely and entered into the BOMO registry by an outpatient nurse.
Analysis and Statistics
Comparison between treatments, combination of treatments, or no treatment was evaluated with analysis of variance and post hoc analysis (Tukey) to examine their effect on time to normalization of PbtO 2 (⌬T), the magnitude of PbtO 2 change (⌬PbtO 2 ) as well as on ⌬ICP and ⌬CPP. To analyze which treatment or combination of treatments, if any, was superior linear regression analysis was used. SPSS software (SPSS, Chicago, IL) was used for analysis. Continuous data are pre- sented as mean Ϯ SD unless otherwise specified and a twotailed p value of Ͻ0.05 was considered statistically significant.
RESULTS
Study Population
Four hundred sixty-two (462) patients who had 1,601 episodes of compromised PbtO 2 (Ͻ20 mm Hg) were identified in the BOMO registry from September 30, 2001 , to October 1, 2008 (Fig. 2 ). From these, 92 patients who had 625 episodes of compromised PbtO 2 (between 15 minutes and 4 hours) were selected once non-TBI patients and entries with insufficient data were removed. Two hundred eighty (280) compromised PbtO 2 episodes received no intervention and normalized within 4 hours, whereas 345 episodes were identified in patients that received some form of intervention before normalization of PbtO 2 . The age and ethnic breakdown of the patients included in this study are illustrated in Figures 3 and 4 . Each patient had an admission head CT scan, and the findings are illustrated in Figure 5 . Table 2 describes the demographic and clinical characteristics of treated patients.
Clinical Course and Outcome
Of the 92 patient cohort, 26% had more than one ICP monitor placed, 9% had placement of a jugular venous bulb monitor and 34% underwent an operative neurosurgical procedure (evacuation of hematoma, decompressive craniectomy). Median hospital length of stay for all cohort patients was 25 (0 -146) days and in hospital mortality was 27.2%. The mean number of episodes of compromised PbtO 2 in patients who survived to discharge was 8 Ϯ 7 compared with 5 Ϯ 5 in those who died in hospital, although those who died generally had a shorter hospital stay and duration of PbtO 2 monitoring. Advanced age, especially Ͼ70 years old was associated with unfavorable outcome using both the GOS-e (p ϭ 0.03) and mRS (p ϭ 0.03). In addition, female sex was associated with better outcome (GOS-e, p ϭ 0.02; mRS, p ϭ 0.01). 
Brain Oxygen Treatment
We examined 92 patients who had 625 episodes of compromised PbtO 2 (280 episodes normalized without receiving an intervention and 345 received some form of intervention). Among episodes of compromised PbtO 2 that received one or more interventions, mean time to PbtO 2 normalization (⌬T) was greater (p Ͻ 0.05) but of similar magnitude (⌬PbtO 2 ) to that observed in episodes that corrected without treatment (Table 3) . One hundred eighty-seven (54% of treated episodes) episodes of compromised PbtO 2 were treated successfully with a single intervention and 101 (30% of treated episodes) with 2 interventions (Table 4 Only one or two interventions were used to correct compromised PbtO 2 in the majority of episodes and so subsequent analyses were limited to these groups. The commonest strategies used to treat compromised PbtO 2 are summarized in Table 6 . The most common single interventions were sedation or analgesia (N ϭ 60), pressors (N ϭ 51), increase in FIO 2 /PEEP (N ϭ 24), and patient repositioning (N ϭ 27; Table 7 ). Of these, pressors were associated with the lowest ⌬T (fastest correction). Single interventions associated with the greatest ⌬PbtO 2 were osmotherapy (14 mm Hg Ϯ 11 mm Hg) and red cell transfusion (27 mm Hg) but the frequency of these interventions was low. No one intervention appeared superior using simple linear regression analysis (R 2 Ͻ 0.2; p Ͼ 0.05). One hundred one episodes were treated with two interventions; the most common was sedation or Table 4 No. of Intervention(s) 38 Tukey posthoc analysis comparing the number of interventions used on time to PbtO 2 correction (⌬T). One or two interventions always correct PbtO 2 significantly faster than 3, 4, or 5 interventions. There is no significance difference when using 1 or 2 interventions to correct PbtO 2 . Table 8 ). Cooling ϩ paralytics (n ϭ 1 episodes) was associated with the lowest ⌬T, and osmotherapy ϩ FIO 2 /PEEP increase (n ϭ 2 episodes) with the greatest ⌬PbtO 2 . An osmotherapy ϩ sedation or narcotics combination appeared to demonstrate an optimal ⌬PbtO 2 /⌬T combination (16.9 mm Hg Ϯ 14.5 mm Hg/0.82 hours Ϯ 0.5 hours) but was only used in five episodes. When controlling for age, sex, Injury Severity Score, and arrival GCS no intervention or combination of interventions appeared to be better than others in correction of compromised PbtO 2 .
PbtO 2 Treatment and the Effect on ICP and CPP
We next examined how PbtO 2 -related treatment influenced ICP and CPP during the same analyzed episodes ( Table  9) . As with ⌬T and ⌬PbtO 2 , use of osmotherapy ϩ sedation or narcotics seemed to best manage ICP but did not translate into an important CPP increase. Pressors, fluids and repositioning were associated with the greatest increases on CPP. When evaluating the number of interventions on ⌬ICP, any three-intervention regimen (Ϫ6.40 mm Hg Ϯ 2.5 mm Hg) had greater ICP reduction than no intervention (Ϫ1.19 mm Hg Ϯ 0.47 mm Hg, p ϭ 0.009), or one intervention (Ϫ1.62 mm Hg Ϯ 0.61 mm Hg, p ϭ 0.03). CPP was most increased with combinations of two interventions (11.1 mm Hg Ϯ 2.4 mm Hg), which was significantly greater than that with no intervention (3.8 mm Hg Ϯ 1.2 mm Hg, p ϭ 0.02). We also evaluated all compromised PbtO 2 episodes that underwent one or more interventions and found a mean decrease of ICP of 1.25 mm Hg Ϯ 5.9 mm Hg and CPP increase of 7.02 Ϯ 17.7 in the interval evaluated. 
DISCUSSION
In this study, we examined 92 severe TBI patients with 625 episodes of compromised PbtO 2 (Ͻ20 mm Hg for 0.25-4 hours) and how these episodes were treated. We observed the following: (1) 44% of episodes were corrected without specific treatment; (2) most episodes of compromised PbtO 2 could be successfully treated with one or two interventions and none required more than five interventions; (3) no single intervention or combination of interventions appeared better than any other to reduce time to PbtO 2 correction or to increase magnitude of PbtO 2 change; (4) use of more interventions was associated with a greater time to PbtO 2 normalization; (5) many episodes underwent PbtO 2 normalization without interventions, and (6) an increasing the number of interventions to a maximum of three only had a favorable effect on ICP or CPP. These data may be used to guide therapy of compromised PbtO 2 and suggest what effect can be expected.
Methodological Limitations
This study has several potential limitations. First, it is a retrospective analysis of interventions recorded in a prospective observational database. Second, the sample size of 92 patients is relatively small. However, we examined Ͼ600 episodes of compromised PbtO 2 . Third, this is a single institution series. Our results, therefore, may lack external validity and should be considered preliminary. Fourth, we defined an episode of compromised PbtO 2 as 15 minutes to 240 minutes in duration. The lower time limit was arbitrarily chosen to prevent transient self-limited changes in PbtO 2 , i.e., episodes of coughing, straining, or moving that bedside clinicians do not routinely treat. Our upper time limit also was arbitrarily chosen. However, we felt it reasonable to conclude that if no treatment was initiated within 4 hours, that care had been deliberately withheld. Fifth, although all specific treatments were prospectively coded in our BOMO registry, we chose, for the purposes of this study, to examine treatment classes or interventions (see Methods), thus, any effects of the specific drug or fluid administered are beyond the scope of this study. Sixth, we did not control for the number of times a specific intervention was used to correct a single episode of compromised PbtO 2 or in which order therapies were given. It was not our goal to describe a precise recipe to treat compromised PbtO 2 because such a recipe is unlikely to exist. Seventh, the intention behind the clinician's use of a given intervention was not examined and the use of a given intervention could have occurred for reasons other than to correct PbtO 2 deficits. Finally, use of ⌬T as a primary outcome may have lead to intrinsic bias because the greater duration of compromised PbtO 2 would inherently allow clinicians more time to administer more interventions. In addition, defining the episode endpoint as normalized PbtO 2 (Ͼ20 mm Hg) may have underestimated any intervention's maximal effect on ⌬PbtO 2 . Despite these limitations, the results of this study from an institution with several years experience using and studying PbtO 2 monitoring by a group of interdisciplinary clinicians provide an in-depth description of what interventions are usually administered to patients with compromised PbtO 2 and what results can be expected.
Significance of Reduced PbtO 2
Increased ICP and reduced CPP are associated with mortality and poor outcome in TBI. [21] [22] [23] [24] Consequently, an ICP monitor is recommended in current severe TBI guidelines in part to also maintain CPP. 5, 6 Although it may appear physiologically plausible, there is no Level I evidence to support the role of an ICP monitor (or any monitor) in TBI care. However, some recent observational cohort studies continue to question the use of ICP monitors, 25, 26 and a recent meta-analysis of the literature suggests that use of an ICP monitor is associated with better outcome. 27 In a separate set of recent studies, the concept that cellular hypoxia or dysfunction may occur when ICP and CPP are normal has emerged. 8,28 -30 In particular, positron emission tomography (PET) and microdialysis studies have found that after TBI, cellular hypoxia or anerobic metabolism often is associated with defects in oxygen diffusion and may be independent of perfusion, 2,3,28,31,32 and therefore not coupled with ICP variations. Consistent with this, several observational clinical studies found that mortality and poor outcome can be associated with brain hypoxia particularly of greater duration, 10,13-15,33,34 magnitude (Ͻ15 mm Hg), 10, [13] [14] [15] 33, 34 or frequency. [13] [14] [15] Consequently, the most recent edition of the BTF Guidelines recommended the use of a brain tissue oxygen monitor. 35 PbtO 2 -Based Care of Severe TBI Several groups have described the use of a PbtO 2 monitor and PbtO 2 -based care to supplement ICP and CPPbased care of severe TBI. [11] [12] [13] [14] [15] Management strategies include protocols to correct CPP when reduced PbtO 2 is observed 12 or tiered approaches based on physiologic targets although the specific individual interventions often are not well detailed. 13 Our usual protocol is illustrated in Figure 1 and described in previous publications. 14 There are seven published reports, all nonrandomized, that compare PbtO 2 and ICP or CPP-guided TBI management strategies. [11] [12] [13] [14] [15] [16] 36 Six of the studies suggest a potential benefit to PbtO 2 -based care and a pooled analysis indicates that PbtO 2 -based care is associated with a twofold increase chance of favorable outcome. 37 However, Martini et al. 11 observed increased hospital mortality associated with PbtO 2 -based care although this was no longer a significant relationship when adjusted for variables such as age, head Abbreviated Injury Scale, Marshall CT classification, and GCS. In addition, these authors found that PbtO 2 -guided care was associated with more use of osmotherapy, vasopressors, and prolonged sedation. However, we have found that among patients treated with PbtO 2 -based care that mortality is associated with longer periods of compromised PbtO 2 deficits (⌬T), and with compromised PbtO 2 that is less responsive to treatment. 14 This balance between effective treatment and overtreatment is crucial because every therapy has potential side-effects and although brain physiology may be improved, this result may not always translate into better outcome if other organ systems are harmed. 38 
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The
Therapeutic Interventions for Compromised PbtO 2
Although clinical series suggest that there may be a benefit to PbtO 2 -based care, it remains unclear what constitutes this care as the specific therapies for compromised PbtO 2 are only beginning to be defined. In this study, we describe what interventions may be used and their expected efficacy when PbtO 2 is compromised. Our registry (BOMO) codes Ͼ80 clinician interventions in the ICU. This includes specific items such as "mouthcare," "proning," "abdominal operation," or "patient reposition" that are recorded in the nursing record at time intervals as short as 10 minutes to 20 minutes. We conducted a detailed evaluation of these coded treatments and, with expert consensus, grouped them in 11 classes of interventions (Table 6 ). Although many of these interventions are used by clinicians caring for TBI patients worldwide and often in the setting of reduced ICP or MAP, there is limited study of how these interventions affect compromised PbtO 2 . We thus sought to first delineate what interventions were used most frequently in TBI patients with compromised PbtO 2 . Greater than one third of such episodes PbtO 2 resolved without any apparent intervention. These episodes may simply have been self-limited and thus raise the question on how to identify reductions in PbtO 2 that do not require treatment. However, they also may represent an episode where some other trigger (e.g., low ICP, high CPP) resulted in treatment initiation before the identified decrease in PbtO 2 and the effect of these intervention(s) eventually also normalized PbtO 2 . Yet, when evaluating the effect of any intervention or combination of interventions on ICP and CPP effects were at most modest.
Specific Interventions for Compromised PbtO 2 -Alone or in Combination?
The use of a single intervention for compromised PbtO 2 was the most frequent strategy, and among these, narcotic analgesics or sedatives, often used in TBI to control ICP, 39 -42 was most common (Table 4) . Pressors were the next most frequent therapy. These agents are also frequently used in TBI care, but which specific agent (phenylephrine, dopamine, norepinephrine) is preferable is not well defined. 43, 44 In addition, overuse of pressors may exacerbate lung function. 5 Of interest, we observed that, among the most popular treatments, pressors appeared to be associated with the shortest time interval for PbtO 2 correction (⌬T). However, this may mean pressors were only used late or after other interventions failed. Patient repositioning was the third most common intervention we observed and often increased PbtO 2 by 10 mm Hg or more. Head and neck repositioning, elevating the head of the bed, turning a patient or loosening a cervical collar are common practice in TBI patients, but the direct effects and durability of these interventions may be more opinion than fact. These maneuvers, however, are recommended as good clinical care and are likely to benefit the patient without significant risk. It is conceivable that we underestimated their use and effect because they most likely were applied as part of general care rather than when a specific monitored abnormality occurred. Efforts to increase available oxygen through increases in FIO 2 , PEEP, or pulmonary dynamics (prostacyclin in other studies) were the fourth most common intervention in our study. [45] [46] [47] [48] [49] The definitive benefits and, more importantly, risks (oxygen toxicity) of hyperoxic treatment in TBI, however, remain unknown.
Combined use of sedation or narcotics ϩ osmotherapy resulted in the most rapid correction of compromised PbtO 2 (about 15 minutes) and also appeared to increase PbtO 2 and reduce ICP by the greatest margins. It must be noted, however, that the occurrence of this combination was exceeding low and therefore no durable conclusion can be made. Both mannitol and hypertonic saline were included in the osmotherapy intervention class and are well known to reduce ICP. 50, 51 Hypertonic saline in particular has been shown to improve PbtO 2 in TBI patients 52 refractive to mannitol therapy. Efforts to enhance oxygen delivery (DO 2 ) through transfusion of red blood cells is commonly used though an improvement in PbtO 2 is not always present. 53, 54 In addition, there remains controversy on what is the optimal hemoglobin level for TBI patients. 7, 55 There is limited data on how other blood products (e.g., plasma) affect PbtO 2 . 56 A combination of pressors and fluid boluses may also improve DO 2 although studies in subarachnoid hemorrhage suggest only induced hypertension has a positive effect on PbtO 2 . 57 In our study, combined pressors and fluids was associated with the greatest increase of CPP (ϳ14 mm Hg). Although infusions of crystalloids or colloids are commonplace in the ICU and thought to benefit TBI patients by raising MAP and CPP, their effect on PbtO 2 remains intuitive with limited scientific evaluation. 58 Indeed, some studies suggests PbtO 2 monitoring may lead to overuse of fluids. 59 Therapies such as induced hypothermia and cerebral spinal fluid (CSF) drainage were used infrequently in our patient cohort and so we cannot make specific conclusions about their use.
CONCLUSIONS
Accumulating evidence suggests that PbtO 2 -directed therapy may provide an advantage over ICP or CPP only guided management. However, there is little data on what interventions should be included in such a PbtO 2 treatment "bundle." Bundled treatments have improved the care of critically ill patients in other fields such as sepsis. 60 However, the individual components may not demonstrate this advantage in the absence of the remaining components and the environment where they are administered. This study does not provide a recipe for the best ICU intervention or combination of interventions to treat compromised PbtO 2 in TBI patients. However, we have learnt several important points. First, clinicians tend to use a small number of treatments and prefer to use combinations of at most one or two to correct compromised PbtO 2 . Second, the most common interventions may improve ICP or CPP but may not always increase PbtO 2 . Third, use of more treatments does not mean more rapid correction of compromised PbtO 2 . This is particularly important because some interventions to correct intracranial abnormalities are known to exacerbate injury in other organ systems of critically ill patients. Finally, some PbtO 2 
DISCUSSION
Dr. William C. Chiu (Baltimore, Maryland): Dr. Pascual and his coauthors from the University of Pennsylvania have presented another study investigating the utility of brain tissue oxygen-directed management of traumatic brain injury. Secondary brain injury is associated with episodes of cerebral ischemia and hypoxia. Most current algorithms for neurologic monitoring use intracranial and cerebral perfusion pressure monitoring-based therapy.
Previous work from this group has suggested that brain tissue oxygen monitoring is safe and that low brain tissue oxygen can be corrected, and may be associated with reduced mortality.
This study has confirmed their previous findings that common interventions employed for TBI management successfully improve episodes of low brain tissue oxygen and that just one or two interventions normalize brain tissue oxygen in the majority of patients.
There are two particular study results that I found most intriguing: one, the combination of sedation and osmotherapy resulted in the most rapid correction of compromised brain tissue oxygen and reduction of ICP.
Change in CPP with this combination was not so impressive. Instead, the combination of pressors and fluids resulted in the greatest increase in CPP but the change in brain tissue oxygen and ICP were only mild.
These findings suggest that interventions that reduce ICP also improve brain tissue oxygen but not CPP. It also reminds us that interventions that improve CPP may simply improve mean arterial pressure without improving ICP.
Two, the proportion of reduced brain tissue oxygen that normalized without treatment was 45 percent. Furthermore, normalization of brain tissue oxygen was more rapid in those patients without intervention compared to those with intervention.
Patients requiring an incremental increase in number of interventions required an associated increased time for normalization of brain tissue oxygen. This finding reminds us of the difficulty in establishing causality in retrospective research.
Patients requiring five interventions to normalize brain tissue oxygen may have had more resistant hypoxia. Therefore, it is probably unfair to conclude that increasing the number of interventions resulted in worsening the time to brain tissue oxygen correction.
I just have two questions for Dr. Pascual, one, in the group of 280 instances of low brain tissue oxygen with no intervention the time to normalization was a mean of 50 minutes. Please speculate on the justification for no interventions during 50 minutes of brain tissue hypoxia.
And, two, based upon your institution's experience, which patients, then, do you recommend should have brain tissue oxygen-directed management?
Dr. Jose L. Pascual (Philadelphia, Pennsylvania): Thank you, Dr. Chiu for your insightful comments.
I have to say that while interesting, the sedation/narcotics plus osmotherapy combination is difficult to interpret in the setting of such few occurrences in the whole sample size.
To address the specific questions, we also were wondering two questions: how is it that no intervention for a mean time of 50 minutes results still in correction of brain tissue oxygen?
We speculated a few answers. One, that brain tissue oxygen in some cases does correct on its own without any intervention. 
